Author

Samir Zuberi

Institutions: University of Virginia Cancer Center, University of Virginia

Observed institutions: University of Virginia Cancer Center, University of Virginia

OpenAlex ID: A5094219829

Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma

2025 · Ipsita Pal, Anuradha Illendula, et al. · Blood · 4

Preclinical Development of a Romidepsin Nanoparticle Demonstrates Superior Tolerability and Efficacy in Models of Human T-Cell Lymphoma and Large Granular Lymphocyte Leukemia

2024 · Ipsita Pal, Anuradha Illendula, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

Extracellular Vesicles in Hematological Malignancies

2025 · Samir Zuberi, Jihane Khalife · Physiology

Abstract 3207: Chemical fabrication and characterization of a novel nanoparticle of the histone deacetylase (HDACi) romidepsin

2024 · Samir Zuberi, Deepthi P. Damera, et al. · Cancer Research

Works count: 5

Citation count: 6

H-index: 2

I10-index: